Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality.

Journal of cellular and molecular medicine - 1 Jan 2000

Gressner O A, Weiskirchen R, Gressner A M

Abstract excerpt

Fibrosis is a frequent, life-threatening complication of most chronic liver diseases. Despite major achievements in the understanding of its pathogenesis, the translation of this knowledge into clinical practice is still limited. In particular, non-invasive and reliable (serum-) biomarkers indicating the activity of fibrogenesis are scarce. Class I biomarkers are defined as serum components having a direct...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Cirrhosis

Share to Liver Disease Diagnosis and Treatment

Share to Liver Diseases and Immunity

Share to Liver physiology and pathology

Source

Open in PubMed Open full text

Identifiers

PMID: 17979881
DOI: 10.1111/j.1582-4934.2007.00092.x
PMCID: PMC4401271

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality.PMID 17979881Read ↗

FibroMAX™: towards a new universal biomarker of liver disease?Semantic proximity Read ↗

Liver fibrogenesis and genetic factors.Semantic proximity Read ↗

Genomics and proteomics in liver fibrosis and cirrhosisSemantic proximity Read ↗

Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Semantic proximity Read ↗

Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis.Semantic proximity Read ↗

Evaluation of the expression of fibrosis-related genes as non-invasive diagnostic biomarkers for cirrhotic HCV-infected patientsSemantic proximity Read ↗

Assessment of liver fibrosis progression and regression by a serological collagen turnover profile.Semantic proximity Read ↗

Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.Semantic proximity Read ↗

Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.Semantic proximity Read ↗

Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population: The Rotterdam Study.Semantic proximity Read ↗

Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseasesSemantic proximity Read ↗

[MODEL FOR PREDICTING THE PROGRESSION OF LIVER FIBROSIS BASED ON BIOCHEMICAL AND GENETIC CRITERIA IN PATIENTS WITH CHRONIC HEPATITIS C].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.